Brief: Cumberland Pharmaceuticals Reports Q3 2020 Results

Cumberland Pharmaceuticals

10/11/2020 21:10

Nov 10 (Reuters) - Cumberland Pharmaceuticals Inc  CPIX.O :
    * CUMBERLAND PHARMACEUTICALS REPORTS THIRD QUARTER 2020
FINANCIAL
RESULTS & COMPANY UPDATE
    * Q3 ADJUSTED EARNINGS PER SHARE $0.02
    * Q3 REVENUE $9.3 MILLION VERSUS $6.9 MILLION
    * Q3 LOSS PER SHARE $0.03
    * CUMBERLAND PHARMA -TO INITIALLY IMPLEMENT A SOFT LAUNCH
FOR
REDITREX DURING Q4, INTENDS TO FOLLOW WITH A FULL COMMERCIAL
LAUNCH OF BRAND NEXT SPRING

Source text for Eikon:  ID:nPnbyYH6sa 
Further company coverage:  CPIX.O 

 ((Reuters.Briefs@thomsonreuters.com;))